Home  »  Business   »  Connect Biopharma Holdings Limited (NASDAQ: CNTB) ...

Connect Biopharma Holdings Limited (NASDAQ: CNTB) – Does It Provide Stability And Growth?

Connect Biopharma Holdings Limited (NASDAQ:CNTB) shares, rose in value on Friday, 05/13/22, with the stock price up by 12.83% to the previous day’s close as strong demand from buyers drove the stock to $0.75.

Actively observing the price movement in the last trading, the stock closed the session at $0.66, falling within a range of $0.6575 and $0.7847. Referring to stock’s 52-week performance, its high was $29.27, and the low was $0.56. On the whole, CNTB has fluctuated by -74.14% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.


With the market capitalization of Connect Biopharma Holdings Limited currently standing at about $43.11 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 31, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0, which is expected to increase to $0 for fiscal year -$3.66 and then to about -$2.11 by fiscal year 2022.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CNTB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CNTB currently trading nearly -59.57% and -72.37% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 23.77, while the 7-day volatility ratio is showing 16.84% which for the 30-day chart, stands at 14.23%. Furthermore, Connect Biopharma Holdings Limited (CNTB)’s average true range (ATR) is 0.20.

Data on historical trading for Connect Biopharma Holdings Limited (NASDAQ:CNTB) indicates that the trading volumes over the past 3 months, they’ve averaged 220.47K. According to company’s latest data on outstanding shares, there are 57.48 million shares outstanding.

Connect Biopharma Holdings Limited’s shares belong to company insiders and institutional investors own 33.91% of the company’s shares. The stock has fallen by -85.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CNTB stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam